Phase 3 Study to Compare Safety and Efficacy of Smoflipid 20% to Intralipid 20% in Hospitalized Neonates and Infants

Clinical trial NCT02579265 · TERMINATED

Trial details

NCT number: NCT02579265
Sponsor: Fresenius Kabi
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Hospitalized Neonates and Infants, Expected to Require Parenteral Nutrition for 28 Days

Start date: 2015-12-01
Primary completion: 2020-04-03
Enrollment: 204

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.